| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
897 |
768 |
$1.21M |
| J2778 |
Injection, ranibizumab, 0.1 mg |
924 |
811 |
$622K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
5,399 |
4,626 |
$320K |
| Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg |
304 |
260 |
$245K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
137 |
109 |
$164K |
| J9035 |
Injection, bevacizumab, 10 mg |
2,146 |
1,939 |
$137K |
| 92134 |
|
7,019 |
6,187 |
$133K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,595 |
1,471 |
$101K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
522 |
488 |
$45K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
358 |
329 |
$17K |
| J7999 |
Compounded drug, not otherwise classified |
191 |
136 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
30 |
30 |
$2K |
| 92202 |
|
15 |
13 |
$80.72 |